AstraZeneca’s pause in key Covid vaccine testing, after a participant fell ill, boosted shares of rival vaccine makers Moderna and Novavax for a second day amid the push to end the pandemic.

The post Covid Report: AstraZeneca Fallout Continues To Propel Moderna, Novavax Stock appeared first on Investor's Business Daily.